Congress seeks files on gp160 vaccine

doi:10.1126/science.8211169

HIV-gp160 vaccine

Inpharma Weekly ◽

10.2165/00128413-199107930-00017 ◽

1991 ◽

Vol &NA; (793) ◽

pp. 8

Author(s):

&NA;

Keyword(s):

Gp160 Vaccine

Download Full-text

HIV-1 recombinant gp160 vaccine given in accelerated dose schedules

Clinical & Experimental Immunology ◽

10.1111/j.1365-2249.1994.tb06122.x ◽

2008 ◽

Vol 98 (2) ◽

pp. 178-184 ◽

Cited By ~ 13

Author(s):

G. J. GORSE ◽

D. H. SCHWARTZ ◽

B. S. GRAHAM ◽

T. J. MATTHEWS ◽

D. M. STABLEIN ◽

...

Keyword(s):

Hiv 1 ◽

Gp160 Vaccine

Download Full-text

Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine.

Journal of Virology ◽

10.1128/jvi.70.3.1953-1960.1996 ◽

1996 ◽

Vol 70 (3) ◽

pp. 1953-1960 ◽

Cited By ~ 113

Author(s):

S P Mossman ◽

F Bex ◽

P Berglund ◽

J Arthos ◽

S P O'Neil ◽

...

Keyword(s):

Simian Immunodeficiency Virus ◽

Subunit Vaccine ◽

Semliki Forest Virus ◽

Immunodeficiency Virus ◽

Gp120 Subunit ◽

Gp160 Vaccine

Download Full-text

Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration

Vaccine ◽

10.1016/s0264-410x(97)80003-5 ◽

1998 ◽

Vol 16 (5) ◽

pp. 493-506 ◽

Cited By ~ 23

Author(s):

G GORSE

Keyword(s):

Gp160 Vaccine

Download Full-text

HIV gp160 vaccine gene therapy (Wyeth-Lederle Vaccines-Malvern)

Drugs in R&D ◽

10.2165/00126839-199901060-00006 ◽

1999 ◽

Vol 1 (6) ◽

pp. 451-452

Author(s):

&NA;

Keyword(s):

Gene Therapy ◽

Vaccine Gene ◽

Gp160 Vaccine

Download Full-text

HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva

Vaccine ◽

10.1016/0264-410x(95)93138-y ◽

1995 ◽

Vol 13 (2) ◽

pp. 209-214 ◽

Cited By ~ 14

Author(s):

Geoffrey J. Gorse ◽

Jason H. Rogers ◽

John E. Perry ◽

Frances D. Newman ◽

Sharon E. Frey ◽

...

Keyword(s):

Hiv 1 ◽

Gp160 Vaccine

Download Full-text

Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine. The National Institute of Allergy and Infectious Diseases-sponsored AIDS Vaccine Evaluation Group.

Clinical and Diagnostic Laboratory Immunology ◽

10.1128/cdli.4.3.302-308.1997 ◽

1997 ◽

Vol 4 (3) ◽

pp. 302-308 ◽

Cited By ~ 2

Author(s):

J S Lambert ◽

R Viscidi ◽

M C Walker ◽

B Clayman ◽

M Winget ◽

...

Keyword(s):

Human Immunodeficiency Virus ◽

Infectious Diseases ◽

Human Immunodeficiency Virus Type ◽

Aids Vaccine ◽

Immunodeficiency Virus ◽

Evaluation Group ◽

Hiv 1 ◽

Gp160 Vaccine ◽

Asymptomatic Hiv

Download Full-text

Human Immunodeficiency Virus (HIV-l) gp160-Specific Lymphocyte Proliferative Responses of Mononuclear Leukocytes from HIV-l Recombinant gp160 Vaccine Recipients

The Journal of Infectious Diseases ◽

10.1093/infdis/163.3.448 ◽

1991 ◽

Vol 163 (3) ◽

pp. 448-453 ◽

Cited By ~ 30

Author(s):

M. C. Keefer ◽

W. Bonnez ◽

N. J. Roberts ◽

R. Dolin ◽

R. C. Reichman

Keyword(s):

Human Immunodeficiency Virus ◽

Mononuclear Leukocytes ◽

Immunodeficiency Virus ◽

Gp160 Vaccine

Download Full-text

HIV-gp160 vaccine

Inpharma Weekly ◽

10.2165/00128413-199107890-00020 ◽

1991 ◽

Vol &NA; (789) ◽

pp. 8

Author(s):

&NA;

Keyword(s):

Gp160 Vaccine

Download Full-text

Enhancement of human immunodeficiency virus (HIV)-specific CD4+ and CD8+ cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine.

Proceedings of the National Academy of Sciences ◽

10.1073/pnas.89.23.11204 ◽

1992 ◽

Vol 89 (23) ◽

pp. 11204-11208 ◽

Cited By ~ 38

Author(s):

S. K. Kundu ◽

D. Katzenstein ◽

L. E. Moses ◽

T. C. Merigan

Keyword(s):

Human Immunodeficiency Virus ◽

T Lymphocyte ◽

Cytotoxic T Lymphocyte ◽

Asymptomatic Patients ◽

Immunodeficiency Virus ◽

Gp160 Vaccine

Download Full-text